Ikarian Capital’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 108 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 120 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 125 |
|
|
2023
Q2 | – | Sell |
-677,300
| Closed | -$2.86M | – | 85 |
|
|
2023
Q1 | $2.86M | Buy |
677,300
+403,868
| +148% | +$1.7M | 0.65% | 27 |
|
|
2022
Q4 | $4.5M | Sell |
273,432
-198,622
| -42% | -$3.27M | 1.09% | 20 |
|
|
2022
Q3 | $6.03M | Sell |
472,054
-425,305
| -47% | -$5.43M | 1.2% | 12 |
|
|
2022
Q2 | $10.5M | Buy |
+897,359
| New | +$10.5M | 1.91% | 7 |
|
|
2021
Q2 | – | Sell |
-181,941
| Closed | -$2.57M | – | 161 |
|
|
2021
Q1 | $2.57M | Buy |
181,941
+106,496
| +141% | +$1.5M | 0.09% | 89 |
|
|
2020
Q4 | $851K | Sell |
75,445
-38,323
| -34% | -$432K | 0.04% | 93 |
|
|
2020
Q3 | $1.5M | Sell |
113,768
-51,232
| -31% | -$676K | 0.11% | 68 |
|
|
2020
Q2 | $1.77M | Buy |
+165,000
| New | +$1.77M | 0.14% | 46 |
|